Trial intelligence / Profile preview

Panitumumab plus XELOX as first-line therapy for colorectal cancer with advanced liver metastases

2007-002007-41Phase 2Completed

Sponsor

Azienda Ospedaliera Ordine Mauriziano

Start

Nov 2007

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1